All News

This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

Second- and third-generation individuals living in Los Angeles, California, demonstrate 35% and 61%, respectively, more of a chance of getting the disease, according to new study results.

Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

Revised program will analyze the once-daily oral combination of doravirine 100 mg and a lower dose of islatravir in adults with HIV-1 infection.

Black women are suggested to be diagnosed with stage 3 HR-positive breast cancer and receive longer neoadjuvant endocrine therapy more often than White women.

Changing one’s diet could change brain health and study results suggest the Mediterranean diet could positively support cognitive function.

New research suggests that 200 g/day of milk can reduce the risk of type 2 diabetes by 10%.

Phase 3 TOPAZ-1 trial of AstraZeneca’s durvalumab demonstrates an improved overall survival benefit.

AstraZeneca’s Lynparza in combination or as a monotherapy demonstrates meaningful survival benefit in long-term follow-up.

Amendments reflecting more contemporary options could raise ethical questions for health care workers.

Study indicates that a diet high in ultra-processed food is more likely to increase the risk of colorectal cancer in men than it is women.

Research suggests cannabis can improve quality of life for patients who suffer from pain and neurological disorders.

Researchers will submit a new drug application to the FDA after a phase 3 trial found that iDose TR slow- and fast-release models met their primary endpoint in patients with glaucoma.

Key questions to ask when deciding whether compounding facilities are the right fit.

Pharmacists should get involved in all the various aspects of their business and with the different professional groups available.

GENDER R25 will provide funding for courses and curricula to improve gender-focused education and equity in pharmacy, as well as other health care fields.

The most important thing you must do is listen to the patient, understand their concerns, and by doing that, you will gain their trust to be able to treat them appropriately.

Pharmacists can educate older adults on risk factors and prevention efforts around herpes zoster.

Analytics allow for a better understanding of the needs of various patient populations and the barriers they face in accessing care.

Although there is no “best” way to determine which route of administration is best, health care providers are optimally positioned to educate patients and help them make the best decision.

Receiving benefits from the SNAP program does not alleviate the issue, according to the analysis.

Analysis shows that individuals who are comfortable sharing their identities with providers are more likely to be satisfied with overall care.

USC Analysis: although generics save US health care systems billions, PBMs jack up prices for employers, government, and patients.

Quadrivalent mRNA influenza vaccine candidate to be evaluated in approximately 25,000 healthy US adults.

Management of marginal zone lymphoma was impacted by the COVID-19 pandemic because some treatment options can reduce B-cell-produced antibodies.

Migraines are multifactorial and patient-specific, causing accessible care and treatments to be limited and ignored.

Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.

While the performance of nasal self-sampling rapid antigen tests for COVID-19 was found to decrease over time, adding oropharyngeal may improve its performance.

Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.